在肝细胞癌中采用细胞疗法的应用
1Department of Clinical Laboratory, Ningbo No. 6 Hospital, Ningbo, China.
Immunology
|July 12, 2023
概括
收养细胞免疫疗法,包括CAR-T细胞,显示出治疗肝细胞癌 (HCC) 的前景. 本综述涵盖了这些新型肝癌治疗方法的当前应用和挑战.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝细胞癌 (HCC) 是一个重大的全球健康挑战,需要创新的治疗方法.
- 肝脏固有的免疫调节特性使免疫疗法成为HCC的有希望的治疗途径.
- 收养细胞免疫疗法正在成为HCC快速发展的治疗方式.
研究的目的:
- 审查用于肝细胞癌的采用细胞免疫疗法的最新进展.
- 提供对HCC采用免疫疗法的当前状态和挑战的全面了解.
- 为未来在HCC治疗中的临床应用提供见解和策略.
主要方法:
- 专注于嵌合抗原受体 (CAR) -T细胞和T细胞受体 (TCR) 工程T细胞.
- 简要讨论瘤透淋巴细胞 (TIL),自然杀手细胞 (NK),细胞因子诱导的杀手细胞 (CIK) 和巨细胞.
- 综合当前关于各种采用免疫疗法在HCC中的应用和挑战的研究.
主要成果:
- 化学抗原受体 (CAR) -T细胞和T细胞受体 (TCR) 工程T细胞是HCC采用免疫疗法的重点领域.
- 其他细胞类型,如TILs,NK细胞,CIK细胞和巨细胞也对HCC免疫治疗的景观作出了贡献.
- 该综述概述了与这些先进的治疗策略相关的应用和固有的挑战.
结论:
- 采用细胞免疫疗法具有显著的潜力,可以改善肝细胞癌治疗的结果.
- 解决与当前采用免疫治疗方法相关的挑战对于临床成功至关重要.
- 本综述旨在通过先进的免疫疗法刺激肝细胞癌的临床管理的新想法.
相关概念视频
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
01:24Tissue Transplantation
408
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
408